(Q40036786)

16 September 2017

title

Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner (English)

1 reference

16 September 2017

Orlando D Gil

1

1 reference

16 September 2017

Catherine Lee

2

1 reference

16 September 2017

Edgardo V Ariztia

3

1 reference

16 September 2017

Feng-Qiang Wang

4

1 reference

16 September 2017

Phillip J Smith

5

1 reference

16 September 2017

Joanie Mayer Hope

6

1 reference

16 September 2017

David A Fishman

7

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

108

1 reference

16 September 2017

issue

2

1 reference

16 September 2017

page(s)

361-369

1 reference

Status of Tumor Markers in Ovarian Cancer Screening

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Early events in ovarian oncogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

The tumor microenvironment: key to early detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

The ins and outs of lysophosphatidic acid signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Lysophospholipid receptors: signaling and biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Novel clusters of receptors for sphingosine-1-phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for "old" ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

The emerging role of lysophosphatidic acid in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Cell-cell adhesion in the normal ovary and ovarian tumors of epithelial origin; an exception to the rule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Cadherins in cancer: implications for invasion and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Morphogenetic roles of classic cadherins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Developmental patterns of cadherin expression and localization in relation to compartmentalized thalamocortical terminations in rat barrel cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Regulation of cadherin-mediated adhesion in morphogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

E-cadherin-catenin cell-cell adhesion complex and human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Ovarian surface epithelium: biology, endocrinology, and pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

The urokinase plasminogen activator receptor as a gene therapy target for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Epithelio-mesenchymal transition in a neoplastic ovarian epithelial hybrid cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Vascular endothelial growth factor-regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Direct cadherin-activated cell signaling: a view from the plasma membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

Ovarian cancer metastasis: integrating insights from disparate model organisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.027

10.1016/J.YGYNO.2007.10.027

7 January 2021

Identifiers

DOI

1 reference

16 September 2017

1 reference